Long-Term Use of Bonviva® for the Treatment of Postmenopausal Osteoporosis: New Evidence
Journal Title: Біль. Суглоби. Хребет - Year 2013, Vol 1, Issue 9
Abstract
Osteoporosis is a disease of great social importance. Its treatment is a complicated problem and is associated with low compliance and a risk for adverse reactions. Ibandronate belongs to a group of bisphosphonates. The performed trials have proven the efficacy of its two formulations (a tablet once monthly and intravenous injection once every 3 months) in reducing the risk of bone fractures. At present there are data on trials of long-term therapy with this drug, which demonstrate its positive effect on bone mineral density and bone metabolism markers. In addition, high safety of the drug has been shown in long-term use.
Authors and Affiliations
O. B. Yershova, K. Yu. Belova, A. V. Nazarova
Keywords
Related Articles
- EP ID EP232504
- DOI -
- Views 81
- Downloads 0
Extraskeletal Effects of Vitamin D
Results of the numerous researches conducted from the moment of vitamin D (VD) discovery emphasize its key role in a regulation of calcium and phosphorus exchange, providing a bone tissue healthy metabolism. It is necess...
10-year probability of major osteoporotic fractures and hip fractures according to Ukrainian model of FRAX® in women with vertebral fractures
Background. Vertebral fractures are one of the severe complications of systemic osteoporosis, which lead to the low-back pain, decrease or loss of efficiency and increase of mortality in older people. FRAX and dual-energ...
Weber-Christian Disease (Clinical Case Description)
Pfeifer-Weber-Christian disease — a rare autoimmune disease with lesions of subcutaneous adipose tissue. Diagnosis and treatment of this rare type of panniсulitis remain unresolved and will be discussed in this article....
Congress of Slovak and Czech Osteologists: International Exchange of Experience
Key highlights of reports of scientists from USA, Austria, Switzerland and Ukraine, that were presented in the Congress of Slovak and Czech Osteologists (8-10 of September, 2016, Zilina, Slovakia) are described in this r...
Long-Term Use of Bonviva® for the Treatment of Postmenopausal Osteoporosis: New Evidence
Osteoporosis is a disease of great social importance. Its treatment is a complicated problem and is associated with low compliance and a risk for adverse reactions. Ibandronate belongs to a group of bisphosphonates. The...